G

G3139, 536

gallium-67 citrate, 823-824

Ga-67 scintigraphy, 823-824

GATA1 mutations, in AML patients, 19

Gaucher's disease and gammopathy, 837

gemtuzumab ozogamicin, 46, 57, 67, 94, 97

gene therapy, for x-linked severe combined immunodeficiency syndrome, 105 G6PD deficiency, 26

graft-versus-host disease (GVHD), 95-96, 98 cellular modulation and separation of, 1055-1056 clinical presentation and pathophysiology of acute GVHD,

1051-1053 prevention of, 1053-1055 treatment of, 1056-1057 granulocyte-colony-stimulating factor, 488 granulocyte-macrophage colony-stimulating factor, 488 granulocytic cells, 1 granulocytic sarcomas, 25-26

0 0

Post a comment